Inventor · disambiguated record
Jason A. Duquette
Also filed as: DUQUETTE I JASON A · DUQUETTE JASON · DUQUETTE JASON A
21 granted patents·11 pending applications·203 citations·filing 2005–2023
95Inventor score
Top patents by PatentIndex Score
32 records- 0192US8623885B2Fused tricyclic dual inhibitors of CDK 4/6 and FLT3CHEN XIAOQI·Filed 2012·Granted Jan 7, 2014·44 cites·35 claims
- 0292US7375102B2Tetrahydroquinazolin-4(3H)-one-related and tetrahydropyrido[2,3-D]pyrimidin-4(3H)-one-related compounds, compositions and methods for their useAMGEN SF LLC·Filed 2005·Granted May 20, 2008·27 cites·24 claims
- 0391US8586739B2Heterocyclic compounds and their usesCHEN YI·Filed 2012·Granted Nov 19, 2013·13 cites·7 claims
- 0491US8193199B2Heterocyclic compounds and their usesCHEN YI·Filed 2008·Granted Jun 5, 2012·15 cites·15 claims
- 0591US7939538B2Compounds, compositions and methods for prevention and treatment of inflammatory and immunoregulatory disorders and diseasesAMGEN INC·Filed 2005·Granted May 10, 2011·20 cites·23 claims
- 0690US8575183B2Heterocyclic compounds and their usesCUSHING TIMOTHY DAVID·Filed 2011·Granted Nov 5, 2013·26 cites·5 claims
- 0789US7799795B2Aryl nitrile compounds and compositions and their uses in treating inflammatory and related disordersAMGEN INC·Filed 2006·Granted Sep 21, 2010·21 cites·17 claims
- 0888US9593129B2Piperidinone derivatives as MDM2 inhibitors for the treatment of cancerAMGEN INC·Filed 2016·Granted Mar 14, 2017·5 cites·18 claims
- 0988US9296736B2Piperidinone derivatives as MDM2 inhibitors for the treatment of cancerAMGEN INC·Filed 2014·Granted Mar 29, 2016·7 cites·13 claims
- 1087US2024300892A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2023·Application pending·0 cites
- 1186US9376425B2Heterocyclic compounds as MDM2 inhibitors for the treatment of cancerAMGEN INC·Filed 2012·Granted Jun 28, 2016·12 cites·37 claims
- 1285US11634396B2Opioid receptor modulatorsEPIODYNE INC·Filed 2022·Granted Apr 25, 2023·1 cites·16 claims
- 1382US11352316B2Opioid receptor modulators and products and methods related theretoEPIODYNE INC·Filed 2020·Granted Jun 7, 2022·1 cites·20 claims
- 1481US11306107B2Compounds that inhibit MCL-1 proteinAMGEN INC·Filed 2017·Granted Apr 19, 2022·2 cites·11 claims
- 1580US8901135B2Heterocyclic compounds and their usesCHEN YI·Filed 2012·Granted Dec 2, 2014·3 cites·16 claims
- 1677US7271271B2Imidazolo-related compounds, compositions and methods for their useAMGEN SF LLC·Filed 2005·Granted Sep 18, 2007·3 cites·14 claims
- 1774US2021179560A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2020·Application pending·0 cites
- 1873US9873701B2Heterocyclic compounds and their usesAMGEN INC·Filed 2014·Granted Jan 23, 2018·1 cites·16 claims
- 1972US7750017B2HeterocyclesBAYER SCHERING PHARMA AG·Filed 2005·Granted Jul 6, 2010·2 cites·10 claims
- 2068US12168648B2Opioid receptor modulatorsEPIODYNE INC·Filed 2023·Granted Dec 17, 2024·0 cites·20 claims
- 2167US2020048265A1Heterocyclic compounds and their usesAMGEN INC·Filed 2019·Application pending·0 cites
- 2267US2019062276A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2018·Application pending·0 cites
- 2365US2014011796A1Piperidinone derivatives as mdm2 inhibitors for the treatment of cancerAMGEN INC·Filed 2013·Application pending·0 cites
- 2464US2017144971A1Piperidinone Derivatives as MDM2 Inhibitors for the Treatment of CancerAMGEN INC·Filed 2017·Application pending·0 cites
- 2563US9359355B2Fused tricyclic dual inhibitors of CDK 4/6 and FLT3AMGEN INC·Filed 2013·Granted Jun 7, 2016·0 cites·14 claims
- 2663US2018105532A1Heterocyclic compounds and their usesAMGEN INC·Filed 2017·Application pending·0 cites
- 2754US2021147343A1Opioid receptor modulators and products and methods related theretoEPIODYNE INC·Filed 2019·Application pending·0 cites
- 2854US2016368933A1Fused tricyclic dual inhibitors of cdk 4/6 and flt3AMGEN INC·Filed 2016·Application pending·0 cites
- 2946US9873704B2Heterocyclic compounds and their usesAMGEN INC·Filed 2016·Granted Jan 23, 2018·0 cites·3 claims
- 3043US8207172B2Pyrimidinothienoindazoles useful for the treatment of hyperproliferative disordersZHANG CHENGZHI·Filed 2005·Granted Jun 26, 2012·0 cites·13 claims
- 3143US2010331306A1Heterocyclic compounds and their usesAMGEN INC·Filed 2010·Application pending·0 cites
- 3235US2013096134A1Heterocyclic compounds and their usesDUQUETTE JASON A·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jason A. Duquette files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →